Frontlight ResearchEarly access
Trial site
Chengdu
- 13running trials
- 7closed trials
The trials here
What the 20 trials at this site are about, from their registry records.
- Conditions
- Asthma4 trials
- Hepatitis B4 trials
- Colorectal cancer3 trials
- COPD2 trials
- Head and neck cancer2 trials
- Lung cancer2 trials
- Multiple myeloma2 trials
- Systemic sclerosis (scleroderma)2 trials
- Chronic rhinosinusitis with nasal polyps1 trial
- Endometrial cancer1 trial
- Gastric and oesophageal cancer1 trial
- Kidney cancer1 trial
- and 1 more
- Phase
- Phase 314 trials
- Phase 24 trials
- Phase 11 trial
- Phase 2/31 trial
- Status
- Recruiting7 trials
- Active, not recruiting6 trials
- Completed6 trials
- Terminated1 trial
- Lead sponsor
- GlaxoSmithKline20 trials
Running trials
Recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
A Study of Dostarlimab in Participants With Untreated Locally Advanced Rectal Cancer in China
Active, not recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
First-Time-in-Human Study of GSK4381562 in Participants With Advanced Solid Tumors
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- COPD2 recruiting
- Systemic sclerosis (scleroderma)2 recruiting
- Colorectal cancer1 recruiting
- Head and neck cancer1 recruiting
- Multiple myeloma1 recruiting
Closed trials
Terminated
Completed
Completed
Completed
Completed
Completed
Completed
Site data: ClinicalTrials.govUpdated 18 Nov 2026